These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 25697974)

  • 1. Decreased expression of human heat shock protein 70 in the endometria and pathological lesions of women with adenomyosis and uterine myoma after GnRH agonist therapy.
    Khan KN; Kitajima M; Hiraki K; Fujishita A; Nakashima M; Masuzaki H
    Eur J Obstet Gynecol Reprod Biol; 2015 Apr; 187():6-13. PubMed ID: 25697974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of GnRH agonist therapy on the expression of human heat shock protein 70 in eutopic and ectopic endometria of women with endometriosis.
    Imamura T; Khan KN; Fujishita A; Kitajima M; Hiraki K; Ishimaru T; Masuzaki H
    Eur J Obstet Gynecol Reprod Biol; 2014 Sep; 180():16-23. PubMed ID: 25016551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in tissue inflammation, angiogenesis and apoptosis in endometriosis, adenomyosis and uterine myoma after GnRH agonist therapy.
    Khan KN; Kitajima M; Hiraki K; Fujishita A; Sekine I; Ishimaru T; Masuzaki H
    Hum Reprod; 2010 Mar; 25(3):642-53. PubMed ID: 20008888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell proliferation effect of GnRH agonist on pathological lesions of women with endometriosis, adenomyosis and uterine myoma.
    Khan KN; Kitajima M; Hiraki K; Fujishita A; Nakashima M; Ishimaru T; Masuzaki H
    Hum Reprod; 2010 Nov; 25(11):2878-90. PubMed ID: 20829343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological differences between focal and diffuse adenomyosis and response to hormonal treatment.
    Khan KN; Fujishita A; Koshiba A; Mori T; Kuroboshi H; Ogi H; Itoh K; Nakashima M; Kitawaki J
    Reprod Biomed Online; 2019 Apr; 38(4):634-646. PubMed ID: 30850322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effects of dienogest on uterine myoma volume: a retrospective controlled study comparing with gonadotropin-releasing hormone agonist.
    Ichigo S; Takagi H; Matsunami K; Suzuki N; Imai A
    Arch Gynecol Obstet; 2011 Sep; 284(3):667-70. PubMed ID: 21052701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression profiles of E/P receptors and fibrosis in GnRHa-treated and -untreated women with different uterine leiomyomas.
    Khan KN; Fujishita A; Koshiba A; Ogawa K; Mori T; Ogi H; Itoh K; Teramukai S; Kitawaki J
    PLoS One; 2020; 15(11):e0242246. PubMed ID: 33186388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological differences between functionalis and basalis endometria in women with and without adenomyosis.
    Khan KN; Fujishita A; Kitajima M; Masuzaki H; Nakashima M; Kitawaki J
    Eur J Obstet Gynecol Reprod Biol; 2016 Aug; 203():49-55. PubMed ID: 27240261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential infiltration of macrophages and prostaglandin production by different uterine leiomyomas.
    Miura S; Khan KN; Kitajima M; Hiraki K; Moriyama S; Masuzaki H; Samejima T; Fujishita A; Ishimaru T
    Hum Reprod; 2006 Oct; 21(10):2545-54. PubMed ID: 16763009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, controlled clinical trial comparing the effects of aromatase inhibitor (letrozole) and gonadotropin-releasing hormone agonist (triptorelin) on uterine leiomyoma volume and hormonal status.
    Parsanezhad ME; Azmoon M; Alborzi S; Rajaeefard A; Zarei A; Kazerooni T; Frank V; Schmidt EH
    Fertil Steril; 2010 Jan; 93(1):192-8. PubMed ID: 19135657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of Talin1 in the eutopic and ectopic endometria of women with adenomyosis.
    Jiang J; Sun A; Wang Y; Deng Y
    Gynecol Endocrinol; 2016 Jun; 32(6):469-72. PubMed ID: 26759065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minodronic acid suppresses gonadotropin-releasing hormone agonist-induced bone remodeling biomarkers: a retrospective pilot study.
    Imai A; Matsunami K; Ichigo S; Takagi H
    Gynecol Endocrinol; 2016; 32(3):250-2. PubMed ID: 26503621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gonadotropin-releasing hormone agonist and danazol normalize aromatase cytochrome P450 expression in eutopic endometrium from women with endometriosis, adenomyosis, or leiomyomas.
    Ishihara H; Kitawaki J; Kado N; Koshiba H; Fushiki S; Honjo H
    Fertil Steril; 2003 Mar; 79 Suppl 1():735-42. PubMed ID: 12620485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptome analysis of eutopic endometrium in adenomyosis after GnRH agonist treatment.
    Tian J; Kang N; Wang J; Sun H; Yan G; Huang C; Mei J
    Reprod Biol Endocrinol; 2022 Jan; 20(1):13. PubMed ID: 35022045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of expressions of Dusp6, Sprouty4, and Sef, negative regulators of FGF2/ERK1/2 signaling, in the endometrium of women with adenomyosis.
    Guo Q; Zhang H; Zhao X; Fu Y; Zhang J; Li M
    Int J Gynecol Pathol; 2014 May; 33(3):288-97. PubMed ID: 24681741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased expression of interleukin-37 in the ectopic and eutopic endometria of patients with adenomyosis.
    Jiang JF; Xiao SS; Xue M
    Gynecol Endocrinol; 2018 Jan; 34(1):83-86. PubMed ID: 28762845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptor 4-mediated growth of endometriosis by human heat-shock protein 70.
    Khan KN; Kitajima M; Imamura T; Hiraki K; Fujishita A; Sekine I; Ishimaru T; Masuzaki H
    Hum Reprod; 2008 Oct; 23(10):2210-9. PubMed ID: 18596029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological changes of uterine leiomyomas after GnRH agonist therapy.
    Grigoriadis C; Papaconstantinou E; Mellou A; Hassiakos D; Liapis A; Kondi-Pafiti A
    Clin Exp Obstet Gynecol; 2012; 39(2):191-4. PubMed ID: 22905461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrantly expressed long noncoding RNAs in the eutopic endometria of patients with uterine adenomyosis.
    Jiang JF; Sun AJ; Xue W; Deng Y; Wang YF
    Eur J Obstet Gynecol Reprod Biol; 2016 Apr; 199():32-7. PubMed ID: 26896594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of preoperative gonadotropin-releasing hormone agonist treatment on women with uterine fibroids: a meta-analysis.
    Zhang Y; Sun L; Guo Y; Cheng J; Wang Y; Fan S; Duan H
    Obstet Gynecol Surv; 2014 Feb; 69(2):100-8. PubMed ID: 25112488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.